Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 2
2011 1
2013 1
2014 1
2018 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Water-solubilised BF(2)-chelated tetraarylazadipyrromethenes.
Tasior M, Murtagh J, Frimannsson DO, McDonnell SO, O'Shea DF. Tasior M, et al. Among authors: frimannsson do. Org Biomol Chem. 2010 Feb 7;8(3):522-5. doi: 10.1039/b919546g. Epub 2009 Nov 16. Org Biomol Chem. 2010. PMID: 20090964
Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.
Wang JH, Forterre AV, Zhao J, Frimannsson DO, Delcayre A, Antes TJ, Efron B, Jeffrey SS, Pegram MD, Matin AC. Wang JH, et al. Among authors: frimannsson do. Mol Cancer Ther. 2018 May;17(5):1133-1142. doi: 10.1158/1535-7163.MCT-17-0827. Epub 2018 Feb 26. Mol Cancer Ther. 2018. PMID: 29483213 Free PMC article.
SENTI-101, a preparation of mesenchymal stromal cells engineered to express IL-12 and IL-21, induces localized and durable anti-tumor immunity in preclinical models of peritoneal solid tumors.
Gonzalez-Junca A, Liu FD, Nagaraja AS, Mullenix A, Lee CT, Gordley RM, Frimannsson DO, Maller O, Garrison BS, Iyer D, Benabbas A, Truong TA, Quach A, Tian M, Martinez R, Savur R, Perry-McNamara A, Nguyen D, Almudhfar N, Blanco C, Huynh C, Nand A, Lay YE, Magal A, Mangalampalli S, Lee PJ, Lu TK, Lee G. Gonzalez-Junca A, et al. Among authors: frimannsson do. Mol Cancer Ther. 2021 Jul 1:molcanther.0030.2021. doi: 10.1158/1535-7163.MCT-21-0030. Online ahead of print. Mol Cancer Ther. 2021. PMID: 34210826
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, Coram MA, Piskun CM, Longacre TA, Herrler M, Frimannsson DO, Telli ML, Dirbas FM, Matin AC, Dairkee SH, Larijani B, Glinsky GV, Bild AH, Jeffrey SS. Zhang H, et al. Among authors: frimannsson do. Breast Cancer Res. 2014 Apr 7;16(2):R36. doi: 10.1186/bcr3640. Breast Cancer Res. 2014. PMID: 24708766 Free PMC article.
11 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page